The CDCN’s Annual “Accelerating Research & Treatment for Castleman Disease,” Working Dinner helps to disseminate cutting edge Castleman disease research
The Castleman Disease Collaborative Network (CDCN) hosted the 10th Annual “Accelerating Research & Treatment for Castleman Disease,” working dinner in a virtual (online) format on Monday, February 7, 2022, outside of our traditional time during the annual American Society of Hematology Meeting.
The CDCN virtual working dinner was attended by physicians and researchers from around the globe, who are dedicated to advancing the understanding and treatment of Castleman disease. The event served as an opportunity for the CDCN’s network of physicians and researchers to discuss cutting edge research and important issues for patient care.
This event was co-sponsored by the CDCN and EUSA Pharma.
The Working Dinner Recording is available here.
The presentation topics and speakers are below.
CD Overview, David Fajgenbaum, MD, MBA, MSc
Treatment of UCD and iMCD, Frits van Rhee, MD, PhD, MRCP (UK), FRCPath
Real world treatment of CD, Sudipto Mukherjee, MD, MPH
Research Update 1: MTOR in CD, Melanie Mumau, PhD
Research Update 2: IL-6/JAK/STAT in CD, Michael Gonzalez, PhD
Research Update 3: CXCL 13 in CD, Sheila Pierson, MS
Accepted abstracts are below.
1: Novel somatic alterations in unicentric and idiopathic multicentric Castleman disease
Submitted by: Aaron Goodman, MD, University of California San Diego
Abstract Link, Poster Link
2: iMCD/TAFRO-A Case Report
Submitted by: Frank Mukonde, MD, Internal Medicine
Kitwe Teaching Hospital & University of Edenberg Kitwe, Zambia
Abstract Link; PowerPoint Slides
3: Ongoing symptoms and reduced health measures in unicentric Castleman disease patients despite perceived-to-be curative surgical excision
Submitted by: Mateo Sarmiento Bustamante, University of Pennsylvania
Abstract Link; Poster Link
4: Safety and Tolerability of SARS-CoV-2 Vaccination and Natural History of Infection Among Patients with Castleman Disease
Submitted by: Russell Perkins, University of Pennsylvania
Abstract Link; Poster Link
5: Evaluating the transcriptome of iMCD-TAFRO
Submitted by: Stacy Guzman, PhD student, University of Pennsylvania
Abstract Link
6: Red Blood Cell Morphological Changes and Enlarged Platelets Found in Idiopathic Multicentric Castleman Disease
Submitted by: Ayelet Rubenstein, University of Pennsylvania
Abstract Link
Recorded Presentation
This annual meeting is a tremendous example of the power of the CDCN’s collaborative research approach to defeating Castleman disease
If you missed last year’s CDCN’s “Accelerating Research & Treatment for Castleman Disease,” Virtual Working Dinner you can view the recording of the presentations here.
The last in-person CDCN Annual “Accelerating Research & Treatment for Castleman Disease,” Working Dinner was held during the 2019 ASH Meeting in Orlando Florida from December 7th to December 10th at the Rosen Centre. Research related to Castleman disease was showcased in the first hour of the Working Dinner.